1	Differential	Differential	B-NP	JJ	O	2	NMOD	-1
2	regulation	regulation	I-NP	NN	O	0	ROOT	16	regulation
3	of	of	B-PP	IN	O	2	NMOD	-1
4	in	in	B-NP	FW	O	5	AMOD	-1
5	vivo	vivo	I-NP	FW	O	6	NMOD	-1
6	angiogenesis	angiogenesis	I-NP	NN	O	3	PMOD	3	angiogenesis
7	by	by	B-PP	IN	O	2	NMOD	-1
8	angiotensin	angiotensin	B-NP	NN	B-protein	10	NMOD	-1
9	II	II	I-NP	CD	I-protein	10	NMOD	-1
10	receptors	receptor	I-NP	NNS	I-protein	7	PMOD	-1
11	.	.	O	.	O	2	P	-1

1	Angiotensin	Angiotensin	B-NP	NN	B-protein	10	NMOD	-1
2	II	II	I-NP	CD	I-protein	1	NMOD	-1
3	(	(	O	(	O	6	DEP	-1
4	ANG	ANG	B-NP	NN	B-protein	6	DEP	-1
5	II	II	I-NP	CD	I-protein	4	NMOD	-1
6	)	)	O	)	O	1	NMOD	-1
7	,	,	O	,	O	10	P	-1
8	a	a	B-NP	DT	O	10	NMOD	-1
9	key	key	I-NP	JJ	O	10	NMOD	-1
10	regulator	regulator	I-NP	NN	O	17	NMOD	0
11	of	of	B-PP	IN	O	10	NMOD	-1
12	blood	blood	B-NP	NN	O	13	NMOD	-1
13	pressure	pressure	I-NP	NN	O	11	PMOD	-1
14	and	and	O	CC	O	17	NMOD	-1
15	body	body	B-NP	NN	O	17	NMOD	-1
16	fluid	fluid	I-NP	NN	O	17	NMOD	-1
17	homeostasis	homeostasis	I-NP	NN	O	19	SUB	-1
18	,	,	O	,	O	17	P	-1
19	exerts	exert	B-VP	VBZ	O	0	ROOT	-1
20	mitogenic	mitogenic	B-NP	JJ	O	21	NMOD	-1
21	effects	effect	I-NP	NNS	O	19	OBJ	0
22	on	on	B-PP	IN	O	19	VMOD	-1
23	endothelial	endothelial	B-NP	JJ	B-cell_type	24	NMOD	-1
24	cells	cell	I-NP	NNS	I-cell_type	22	PMOD	-1
25	.	.	O	.	O	19	P	-1

1	We	We	B-NP	PRP	O	3	SUB	-1
2	therefore	therefore	B-ADVP	RB	O	3	VMOD	-1
3	hypothesized	hypothesize	B-VP	VBD	O	0	ROOT	-1
4	that	that	B-SBAR	IN	O	3	VMOD	-1
5	ANG	ANG	B-NP	NN	B-protein	7	SUB	-1
6	II	II	I-NP	CD	I-protein	5	NMOD	-1
7	could	could	B-VP	MD	O	4	SBAR	-1
8	be	be	I-VP	VB	O	7	VC	-1
9	a	a	B-NP	DT	O	10	NMOD	-1
10	mediator	mediator	I-NP	NN	O	8	PRD	16	mediator
11	between	between	B-PP	IN	O	10	NMOD	-1
12	homeostatic	homeostatic	B-NP	JJ	O	13	NMOD	-1
13	changes	change	I-NP	NNS	O	11	PMOD	16	changes
14	within	within	B-PP	IN	O	13	NMOD	-1
15	the	the	B-NP	DT	O	18	NMOD	-1
16	vascular	vascular	I-NP	JJ	O	18	NMOD	-1
17	perfusion	perfusion	I-NP	NN	O	18	NMOD	0
18	bed	bed	I-NP	NN	O	22	NMOD	-1
19	and	and	O	CC	O	22	NMOD	-1
20	growth	growth	B-NP	NN	O	22	NMOD	0
21	factor-driven	factor-driven	I-NP	JJ	O	22	NMOD	-1
22	angiogenesis	angiogenesis	I-NP	NN	O	14	PMOD	3	angiogenesis
23	.	.	O	.	O	3	P	-1

1	In	In	B-PP	IN	O	7	VMOD	-1
2	the	the	B-NP	DT	O	4	NMOD	-1
3	present	present	I-NP	JJ	O	4	NMOD	0
4	study	study	I-NP	NN	O	1	PMOD	-1
5	,	,	O	,	O	7	P	-1
6	we	we	B-NP	PRP	O	7	SUB	-1
7	applied	apply	B-VP	VBD	O	0	ROOT	-1
8	the	the	B-NP	DT	O	12	NMOD	-1
9	alginate	alginate	I-NP	JJ	O	12	NMOD	-1
10	implant	implant	I-NP	NN	O	12	NMOD	19	implant
11	angiogenesis	angiogenesis	I-NP	NN	O	12	NMOD	3	angiogenesis
12	model	model	I-NP	NN	O	7	OBJ	-1
13	in	in	B-PP	IN	O	12	NMOD	-1
14	mice	mouse	B-NP	NNS	O	13	PMOD	-1
15	with	with	B-PP	IN	O	14	NMOD	-1
16	normal	normal	B-NP	JJ	O	19	NMOD	-1
17	ANG	ANG	I-NP	NN	B-protein	19	NMOD	-1
18	II	II	B-NP	CD	I-protein	19	NMOD	-1
19	levels	level	I-NP	NNS	O	15	PMOD	-1
20	,	,	O	,	O	7	P	-1
21	elevated	elevated	B-NP	JJ	O	24	NMOD	17	elevated
22	ANG	ANG	I-NP	NN	B-protein	24	NMOD	-1
23	II	II	B-NP	CD	I-protein	24	NMOD	-1
24	levels	level	I-NP	NNS	O	7	VMOD	-1
25	by	by	B-PP	IN	O	24	NMOD	-1
26	transgenic	transgenic	B-NP	JJ	O	27	NMOD	0
27	overexpression	overexpression	I-NP	NN	O	25	PMOD	9	overexpression
28	of	of	B-PP	IN	O	27	NMOD	-1
29	angiotensinogen	angiotensinogen	B-NP	NN	O	28	PMOD	-1
30	(	(	O	(	O	32	DEP	-1
31	AOGEN	AOGEN	B-NP	NN	B-protein	32	DEP	-1
32	)	)	O	)	O	29	NMOD	-1
33	,	,	O	,	O	39	P	-1
34	or	or	O	CC	O	39	NMOD	-1
35	in	in	B-PP	IN	O	34	PRD	-1
36	AT2	AT2	B-NP	NN	O	38	NMOD	-1
37	receptor-deficient	receptor-deficient	I-NP	JJ	O	38	NMOD	9	deficient
38	mice	mouse	I-NP	NNS	O	35	PMOD	-1
39	.	.	O	.	O	24	P	-1

1	We	We	B-NP	PRP	O	2	SUB	-1
2	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT	-1
3	that	that	B-SBAR	IN	O	2	VMOD	-1
4	a	a	B-NP	DT	O	5	NMOD	-1
5	decrease	decrease	I-NP	NN	O	28	SUB	18	decrease
6	in	in	B-PP	IN	O	5	NMOD	-1
7	the	the	B-NP	DT	O	8	NMOD	-1
8	amount	amount	I-NP	NN	O	6	PMOD	-1
9	of	of	B-PP	IN	O	8	NMOD	-1
10	circulating	circulate	B-VP	VBG	O	9	PMOD	0
11	ANG	ANG	B-NP	NN	B-protein	10	OBJ	-1
12	II	II	I-NP	CD	I-protein	11	NMOD	-1
13	by	by	B-PP	IN	O	5	NMOD	-1
14	the	the	B-NP	DT	O	16	NMOD	-1
15	angiotensin-converting	angiotensin-converting	I-NP	JJ	B-protein	16	NMOD	-1
16	enzyme	enzyme	I-NP	NN	I-protein	21	NMOD	-1
17	(	(	O	(	O	19	DEP	-1
18	ACE	ACE	B-NP	NN	O	19	DEP	-1
19	)	)	O	)	O	16	NMOD	-1
20	inhibitor	inhibitor	B-NP	NN	O	21	NMOD	0
21	enalapril	enalapril	I-NP	NN	O	27	NMOD	-1
22	or	or	O	CC	O	27	NMOD	-1
23	the	the	B-NP	DT	O	27	NMOD	-1
24	AT1	AT1	I-NP	NN	O	27	NMOD	-1
25	receptor	receptor	I-NP	NN	O	27	NMOD	-1
26	antagonist	antagonist	I-NP	NN	O	27	NMOD	-1
27	losartan	losartan	I-NP	NN	O	13	PMOD	-1
28	induced	induce	B-VP	VBD	O	3	SBAR	17	induced
29	a	a	B-NP	DT	O	30	NMOD	-1
30	stimulation	stimulation	I-NP	NN	O	28	OBJ	17	stimulation
31	of	of	B-PP	IN	O	30	NMOD	-1
32	in	in	B-NP	FW	O	33	AMOD	-1
33	vivo	vivo	I-NP	FW	O	34	NMOD	-1
34	angiogenesis	angiogenesis	I-NP	NN	O	31	PMOD	3	angiogenesis
35	implying	imply	B-VP	VBG	O	34	NMOD	-1
36	an	an	B-NP	DT	O	38	NMOD	-1
37	inhibitory	inhibitory	I-NP	JJ	O	38	NMOD	0
38	function	function	I-NP	NN	O	35	OBJ	-1
39	of	of	B-PP	IN	O	38	NMOD	-1
40	ANG	ANG	B-NP	NN	B-protein	39	PMOD	-1
41	II	II	I-NP	CD	I-protein	40	NMOD	-1
42	through	through	B-PP	IN	O	35	VMOD	0
43	the	the	B-NP	DT	O	45	NMOD	-1
44	AT1	AT1	I-NP	NN	B-protein	45	NMOD	-1
45	receptor	receptor	I-NP	NN	I-protein	42	PMOD	-1
46	.	.	O	.	O	2	P	-1

1	However	However	B-ADVP	RB	O	19	VMOD	-1
2	,	,	O	,	O	19	P	-1
3	the	the	B-NP	DT	O	5	NMOD	-1
4	strong	strong	I-NP	JJ	O	5	NMOD	-1
5	increase	increase	I-NP	NN	O	19	SUB	17	increase
6	of	of	B-PP	IN	O	5	NMOD	-1
7	angiogenesis	angiogenesis	B-NP	NN	O	6	PMOD	3	angiogenesis
8	in	in	B-PP	IN	O	5	NMOD	-1
9	AOGEN-transgenic	AOGEN-transgenic	B-NP	JJ	O	10	NMOD	-1
10	mice	mouse	I-NP	NNS	O	8	PMOD	-1
11	compared	compare	B-PP	VBN	O	5	NMOD	-1
12	with	with	B-PP	IN	O	11	PMOD	-1
13	mice	mouse	B-NP	NNS	O	12	PMOD	-1
14	with	with	B-PP	IN	O	13	NMOD	-1
15	normal	normal	B-NP	JJ	O	18	NMOD	-1
16	ANG	ANG	I-NP	NN	B-protein	18	NMOD	-1
17	II	II	B-NP	CD	I-protein	18	NMOD	-1
18	levels	level	I-NP	NNS	O	14	PMOD	-1
19	suggests	suggest	B-VP	VBZ	O	0	ROOT	-1
20	additional	additional	B-NP	JJ	O	22	NMOD	-1
21	stimulatory	stimulatory	I-NP	JJ	O	22	NMOD	-1
22	activity	activity	I-NP	NN	O	19	OBJ	0
23	.	.	O	.	O	19	P	-1

1	We	We	B-NP	PRP	O	2	SUB	-1
2	showed	show	B-VP	VBD	O	0	ROOT	-1
3	that	that	B-SBAR	IN	O	2	VMOD	-1
4	the	the	B-NP	DT	O	7	NMOD	-1
5	ANG	ANG	I-NP	NN	O	7	NMOD	-1
6	II-induced	II-induced	I-NP	JJ	O	7	NMOD	17	induced
7	stimulation	stimulation	I-NP	NN	O	10	SUB	17	stimulation
8	of	of	B-PP	IN	O	7	NMOD	-1
9	angiogenesis	angiogenesis	B-NP	NN	O	8	PMOD	3	angiogenesis
10	is	be	B-VP	VBZ	O	3	SBAR	-1
11	linked	link	I-VP	VBN	O	10	VC	0
12	to	to	B-PP	TO	O	11	VMOD	-1
13	the	the	B-NP	DT	O	15	NMOD	-1
14	AT2	AT2	I-NP	NN	B-protein	15	NMOD	-1
15	receptor	receptor	I-NP	NN	I-protein	12	PMOD	-1
16	as	as	B-PP	IN	O	11	VMOD	-1
17	an	an	B-NP	DT	O	19	NMOD	-1
18	impaired	impaired	I-NP	JJ	O	19	NMOD	18	impaired
19	induction	induction	I-NP	NN	O	16	PMOD	17	induction
20	of	of	B-PP	IN	O	19	NMOD	-1
21	angiogenesis	angiogenesis	B-NP	NN	O	20	PMOD	3	angiogenesis
22	was	be	B-VP	VBD	O	10	VMOD	-1
23	obtained	obtain	I-VP	VBN	O	22	VC	0
24	in	in	B-PP	IN	O	23	VMOD	-1
25	AT2	AT2	B-NP	NN	O	28	NMOD	-1
26	receptor	receptor	I-NP	NN	O	28	NMOD	-1
27	knockout	knockout	I-NP	NN	O	28	NMOD	9	knockout
28	mice	mouse	I-NP	NNS	O	24	PMOD	-1
29	.	.	O	.	O	2	P	-1

1	These	These	B-NP	DT	O	2	NMOD	-1
2	findings	finding	I-NP	NNS	O	3	SUB	-1
3	provide	provide	B-VP	VBP	O	0	ROOT	-1
4	the	the	B-NP	DT	O	6	NMOD	-1
5	first	first	I-NP	JJ	O	6	NMOD	-1
6	evidence	evidence	I-NP	NN	O	3	OBJ	-1
7	that	that	B-SBAR	IN	O	6	NMOD	-1
8	the	the	B-NP	DT	O	10	NMOD	-1
9	AT2	AT2	I-NP	NN	B-protein	10	NMOD	-1
10	receptor	receptor	I-NP	NN	I-protein	11	SUB	-1
11	mediates	mediate	B-VP	VBZ	O	7	SBAR	16	mediates
12	a	a	B-NP	DT	O	13	NMOD	-1
13	stimulation	stimulation	I-NP	NN	O	11	OBJ	17	stimulation
14	of	of	B-PP	IN	O	13	NMOD	-1
15	in	in	B-NP	FW	O	16	AMOD	-1
16	vivo	vivo	I-NP	FW	O	17	NMOD	-1
17	angiogenesis	angiogenesis	I-NP	NN	O	14	PMOD	3	angiogenesis
18	and	and	O	CC	O	3	VMOD	-1
19	indicate	indicate	B-VP	VBP	O	3	VMOD	-1
20	that	that	B-SBAR	IN	O	19	VMOD	-1
21	ANG	ANG	B-NP	NN	B-protein	23	SUB	-1
22	II	II	I-NP	CD	I-protein	21	NMOD	-1
23	is	be	B-VP	VBZ	O	20	SBAR	-1
24	a	a	B-NP	DT	O	26	NMOD	-1
25	humoral	humoral	I-NP	JJ	O	26	NMOD	-1
26	regulator	regulator	I-NP	NN	O	23	PRD	0
27	of	of	B-PP	IN	O	26	NMOD	-1
28	peripheral	peripheral	B-NP	JJ	O	29	NMOD	-1
29	angiogenesis	angiogenesis	I-NP	NN	O	27	PMOD	3	angiogenesis
30	involving	involve	B-VP	VBG	O	29	NMOD	0
31	two	two	B-NP	CD	O	33	NMOD	-1
32	receptor	receptor	I-NP	NN	O	33	NMOD	-1
33	subtypes	subtype	I-NP	NNS	O	30	OBJ	-1
34	with	with	B-PP	IN	O	33	NMOD	-1
35	opposing	oppose	B-NP	VBG	O	36	NMOD	-1
36	actions	action	I-NP	NNS	O	34	PMOD	-1
37	.	.	O	.	O	3	P	-1

